Teva issues multi-tranche notes worth $3.2B and €1.5B
Teva completed a multi-currency senior unsecured notes offering totaling $3.2 billion and €1.5 billion to refinance debt and enhance financial flexibility.
5 billion, with the proceeds earmarked to refinance debt and improve financial flexibility. 625% notes due 2036 issued by Teva Pharmaceutical.